4//SEC Filing
Henrich Jill 4
Accession 0000905148-24-002302
CIK 0001604464other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:26 PM ET
Size
6.7 KB
Accession
0000905148-24-002302
Insider Transaction Report
Form 4
Henrich Jill
EVP, Chief Regulatory Officer
Transactions
- Sale
Common Stock
2024-08-16$6.63/sh−831$5,509→ 20,510 total - Sale
Common Stock
2024-08-16$6.63/sh−132$875→ 20,378 total
Footnotes (3)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
- [F3]This amount includes 4,284 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2024, and reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001978096
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 6:26 PM ET
- Size
- 6.7 KB